American Water Works Company Inc vs Moderna, Inc. — how do they compare? American Water Works Company Inc trades at $131.69 (market cap $25.69B), while Moderna, Inc. trades at $67.22 (market cap $26.59B). The key difference: American Water Works Company Inc and Moderna, Inc. are close in size by market cap, and American Water Works Company Inc pays a 2.72% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| AWK | MRNA | |
|---|---|---|
Market Cap | $25.69B | $26.59B |
Sector | Utilities | Health |
52-Week High | $147.00 | $81.80 |
52-Week Low | $121.13 | $22.36 |
Enterprise Value | $41.25B | $22.68B |
Dividend Yield | 2.72% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $67.01, down 1.85% today, with a bullish technical signal from moving averages. The company continues to post net losses despite beating EPS estimates in recent quarters, with revenue declining from pandemic peaks. Recent news highlights pipeline expansion into oncology and autoimmune diseases, with an FDA decision on its mRNA flu vaccine expected by August 5, 2026.
While Moderna's pipeline diversification offers long-term growth potential, significant risks remain from persistent negative profitability and high valuation multiples. Analyst consensus is cautious with a $49 price target below current levels, suggesting limited near-term upside despite recent positive developments in vaccine approvals and strategic shifts.
Trailing returns across standard periods
Latest headlines on both assets
American Water Works is the largest investor-owned U.S. water and wastewater utility, serving approximately 3.5 million customers in 16 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's only nonregulated business is water services for military bases, which operates under long-term contracts.
Read more on AWK →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →